Idifarma adds contract capsule filling to offering

By Staff Reporter

- Last updated on GMT

iStock/FernandoDT
iStock/FernandoDT

Related tags Investment Capital accumulation

Idifarma has bolstered its capsule filling capabilities at its manufacturing plant in Pamplona, Spain.

The Spanish contract development and manufacturing organisation (CDMO) has installed a Bosch GKF-702 filling machine with capacity to produce 42,000 capsules an hour at the site.

Idifarma said the technology strengthens its position as a producer of oral solid dosage forms, with a particular focus on niche and small batch pharmaceutical products.

Luis Oquiñena, general manager and co-founder of Idifarma, said: “The GKF-702’s modular design will help us to future proof our investment ensuring that we can add real value to our clients’ manufacturing and development projects over the coming years.

He added: “It is important for us to remain versatile and flexible, however, we will continue to focus on specialised low-volume and high potent pharmaceutical products which is a key differentiator for us​.”

Idifarma announced its intention to introduce a contract capsule filling service in December​.

The investment fits with the plan outlined when active pharmaceutical ingredient (API) manufacturer Suanfarma invested in Idifarma in September​ last year.

At the time director of business development Manuel Leal Sanchez told us “Our plan is to keep serving and growing our client base as we invest in other technologies for development and manufacturing.”

Related news

Show more

Related products

show more

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Product Brochure

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Follow us

Products

View more

Webinars